|
Synonyms: garetosmab-grts | Pasatru® | REGN-2477 | REGN2477
garetosmab is an approved drug
Compound class:
Antibody
Comment: Garetosmab (REGN2477) is a fully human anti-activin A (INHBA) monoclonal antibody [4]. The antibody blocks signaling of activins containing the inhibin βα subunit (i.e., activins A, AB, and AC). Peptide sequence matches in a patent search suggests that garetosmab is antibody H4H10446P2 in Regeneron Pharmaceuticals' patent US9718881B2 [3].
|
Classification ![]() |
|
| Compound class | Antibody |
| Approved drug? | Yes. US FDA (2026) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11041 | garetosmab |
Synonyms ![]() |
| garetosmab-grts | Pasatru® | REGN-2477 | REGN2477 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 678 |
| Other databases | |
| GtoPdb PubChem SID | 530846916 |
| Search PubMed clinical trials | garetosmab |
| Search PubMed titles | garetosmab |
| Search PubMed titles/abstracts | garetosmab |